Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Use benzoyl peroxide, retinoids, antibiotics, and isotretinoin for acne, and combine treatments for better results.

Tinea capitis, a scalp fungal infection in children, is best treated with newer antifungal agents for shorter periods.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

The woman's widespread skin condition did not improve despite various treatments.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Biologics for severe asthma have known side effects, but some new risks need more study.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.